Status:
COMPLETED
"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"
Lead Sponsor:
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
Conditions:
Infertility
Reproductive Techniques, Assisted
Eligibility:
FEMALE
20-43 years
Brief Summary
The study evaluated the effect of serum relaxin and follicular fluid levels on the number and quality of oocytes, fertilization, the number and quality of the embryos in IVF protocols.
Detailed Description
Relaxin is one of the promising indicators of oocyte quality and prognosis of the effectiveness of invitro fertilization protocols. The hormone plays an important role in the processes of folliculogen...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Primary or Secondary infertility
- Must be signed the voluntary informed consent to participate in the study.
Exclusion
- The presence of IVF contra-indications.
- Clinical diagnosis of large uterine fibroids.
- BMI\> 35 kg / m2
- Morphological diagnosis of endometrial hyperplastic processes
- Clinical diagnosis of infectious.
- Clinical diagnosis of systemic autoimmune diseases.
- Insulin dependent diabetes
- Oncological diseases
Key Trial Info
Start Date :
December 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04458454
Start Date
December 2 2019
End Date
February 20 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DOOttResearch
Saint Petersburg, Russia